Skip to content

Prospective Study on a Novel Port-site Closure Device (EZ Close): Effectiveness and Comparison With Carter-Thomason

Single Blind Randomized Control Trial Evaluating Efficacy and Safety of EZ-Close Port-site Closure Device Versus Carter-Thomason Device

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03374189
Enrollment
79
Registered
2017-12-15
Start date
2017-08-17
Completion date
2018-05-24
Last updated
2019-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical Port Site Hernia

Brief summary

This study aims to evaluate the efficacy and safety of a novel port-site closure device (EZ Close) by comparing it with the Carter-Thomason device.

Detailed description

Port-site closure is a critical procedure after every laparoscopic surgery. Complications such as visceral organ injury, port-site hernia, infection, ascitic fluid leakage may occur during and after the procedure. Many devices were developed and utilized for the procedure and Carter-Thomason is one of the most commonly used device and validated with several studies. This study aims to evaluate the efficacy and safety of a novel port-site closure device (EZ Close) by comparing it with the Carter-Thomason device.

Interventions

DEVICEEZ close

EZ close used.

DEVICECarter Thomason

Carter Thomason used.

Sponsors

Saint Vincent's Hospital, Korea
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
19 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* All patients with laparoscopic ports over 10mm

Exclusion criteria

* Patients with laparoscopic ports under 10mm * Patients who refused the study * Patients who received concurrent surgery for other reason

Design outcomes

Primary

MeasureTime frameDescription
Time Taken to Complete ClosureAt the time of surgeryThe start of the procedure was defined as the point when the device was first inserted through the port-site and the end of the procedure was defined as the point when the port-site was removed from the port-site. A stopwatch was used to measure the time.

Secondary

MeasureTime frameDescription
Number of Participants With Need for Additional InstrumentAt the time of surgeryNeed for additional instrument during procedure
Number of Participants With Port-site Hernia3 days post-op and within one months of surgeryHerniation of bowel segments through port-site
Number of Participants With Visceral Organ InjuryAt the time of surgeryAny inadvertent injury to organs or bleeding during procedure.
Number of Participants With Ascitic Fluid Leakage3 days post-op and within one months of surgeryNon-infective fluid leakage
Number of Participants With Wound Dehiscence3 days post-op and within one months of surgeryWound dehiscence that required further treatment
Number of Participants With Port-site Infection3 days post-op and within one months of surgeryRedness, purulent discharge, tenderness at port-site

Countries

South Korea

Participant flow

Recruitment details

Eligible patients recruited between July 2017 and June 2018 at St. Vincent's Hospital.

Participants by arm

ArmCount
EZ Close Arm
EZ close used for port-site closure. EZ close: EZ close used.
39
Carter Thomason Arm
Carter Thomason used for port-site closure. Carter Thomason: Carter Thomason used.
39
Total78

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up10

Baseline characteristics

CharacteristicEZ Close ArmCarter Thomason ArmTotal
Age, Continuous65.3 years
STANDARD_DEVIATION 10
58.8 years
STANDARD_DEVIATION 16.2
62.1 years
STANDARD_DEVIATION 13.8
Body mass index23.2 kg/m^2
STANDARD_DEVIATION 2.8
23.6 kg/m^2
STANDARD_DEVIATION 3.1
23.4 kg/m^2
STANDARD_DEVIATION 2.9
Operation time211.7 minutes
STANDARD_DEVIATION 90
217.3 minutes
STANDARD_DEVIATION 77.6
214.5 minutes
STANDARD_DEVIATION 83.6
Operation type
Laparoscopic partial nephrectomy
1 Participants1 Participants2 Participants
Operation type
Laparoscopic radical cystectomy
2 Participants3 Participants5 Participants
Operation type
Laparoscopic radical nephrectomy
4 Participants6 Participants10 Participants
Operation type
Laparoscopic radical prostatectomy
4 Participants5 Participants9 Participants
Operation type
Others
2 Participants4 Participants6 Participants
Operation type
Robot-assisted partial nephrectomy
8 Participants8 Participants16 Participants
Operation type
Robot-assisted radical cystectomy
2 Participants1 Participants3 Participants
Operation type
Robot-assisted radical nephrectomy
0 Participants1 Participants1 Participants
Operation type
Robot-assisted radical prostatectomy
16 Participants10 Participants26 Participants
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Female
8 Participants11 Participants19 Participants
Sex: Female, Male
Male
31 Participants28 Participants59 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 390 / 39
other
Total, other adverse events
0 / 390 / 39
serious
Total, serious adverse events
0 / 390 / 39

Outcome results

Primary

Time Taken to Complete Closure

The start of the procedure was defined as the point when the device was first inserted through the port-site and the end of the procedure was defined as the point when the port-site was removed from the port-site. A stopwatch was used to measure the time.

Time frame: At the time of surgery

ArmMeasureValue (MEAN)Dispersion
EZ Close ArmTime Taken to Complete Closure36.8 secondsStandard Deviation 10.1
Carter Thomason ArmTime Taken to Complete Closure48.9 secondsStandard Deviation 21.5
Secondary

Number of Participants With Ascitic Fluid Leakage

Non-infective fluid leakage

Time frame: 3 days post-op and within one months of surgery

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
EZ Close ArmNumber of Participants With Ascitic Fluid Leakage0 Participants
Carter Thomason ArmNumber of Participants With Ascitic Fluid Leakage0 Participants
Secondary

Number of Participants With Need for Additional Instrument

Need for additional instrument during procedure

Time frame: At the time of surgery

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
EZ Close ArmNumber of Participants With Need for Additional Instrument0 Participants
Carter Thomason ArmNumber of Participants With Need for Additional Instrument33 Participants
Secondary

Number of Participants With Port-site Hernia

Herniation of bowel segments through port-site

Time frame: 3 days post-op and within one months of surgery

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
EZ Close ArmNumber of Participants With Port-site Hernia0 Participants
Carter Thomason ArmNumber of Participants With Port-site Hernia0 Participants
Secondary

Number of Participants With Port-site Infection

Redness, purulent discharge, tenderness at port-site

Time frame: 3 days post-op and within one months of surgery

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
EZ Close ArmNumber of Participants With Port-site Infection1 Participants
Carter Thomason ArmNumber of Participants With Port-site Infection2 Participants
Secondary

Number of Participants With Visceral Organ Injury

Any inadvertent injury to organs or bleeding during procedure.

Time frame: At the time of surgery

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
EZ Close ArmNumber of Participants With Visceral Organ Injury0 Participants
Carter Thomason ArmNumber of Participants With Visceral Organ Injury0 Participants
Secondary

Number of Participants With Wound Dehiscence

Wound dehiscence that required further treatment

Time frame: 3 days post-op and within one months of surgery

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
EZ Close ArmNumber of Participants With Wound Dehiscence0 Participants
Carter Thomason ArmNumber of Participants With Wound Dehiscence0 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026